期刊名称：DRUG DEVELOPMENT RESEARCH
 期刊简介(About the journal)
投稿须知(Instructions to Authors)
编辑部信息(Editorial Board)
About the journal
| Drug development research |
| ISSN: 0272-4391 |
| eISSN: 1098-2299 |
Drug Development Research focuses on research topics related to the discovery and development of new therapeutic entities. The journal publishes original research articles on medicinal chemistry, pharmacology, biotechnology and biopharmaceuticals, toxicology, and drug delivery, formulation, and pharmacokinetics. The journal welcomes manuscripts on new compounds and technologies in all areas focused on human therapeutics, as well as global management, health care policy, and regulatory issues involving the drug discovery and development process. In addition to full-length articles, Drug Development Research publishes Brief Reports on important and timely new research findings, as well as in-depth review articles. The journal also features periodic special thematic issues devoted to specific compound classes, new technologies, and broad aspects of drug discovery and development.
Instructions to Authors
What to submit
1. Diskette in PC compatible format¡ªpreferably Microsoft.
2. Three paper copies of the manuscript and figures.
3. Where necessary, copyright permission for use of data previously published.
4. Notation of programs used for text, figure, and table preparation.
NOTE: If all programs used for the preparation of the manuscripts are Microsoft Word-based, submissions can be made electronically.
Submit to:
Dr. Michael Williams
Dept. of Molecular Pharmacology and Biological Chemistry
Northwestern University Medical School
1130 Walden Lane
Lake Forest, IL 60045-3325
USA
Fax: 847-615-8547
E-mail: mazarine1643@comcast.net
-or-
Prof. Flaminio Cattabeni
Institute of Pharmacological Sciences
University of Milan
Via Balzaretti 9
20133 Milan
Italy
E-mail: flaminio.cattabeni@unimi.it
Format
English, double-spaced in 10-point size type. Typeface is Arial or Helvetica.
Title page with:
- title;
- affiliation of authors with phone, fax, and e-mail information;
- running title with a maximum length of 50 characters including spaces;
- three to five keywords;
- funding/support information;
- total number of text pages, figures, tables.
Abstract: Maximum of 250 words on a separate page. Abstract should be intelligible without reference to the rest of the paper.
Text divided into:
- Introduction;
- Methods and Materials;
- Results;
- Discussion;
- Acknowledgment.
References
Wiley's Journal Styles Are Now in EndNote
EndNote is a software product that we recommend to our journal authors to help simplify and streamline the research process. Using EndNote's bibliographic management tools, you can search bibliographic databases, build and organize your reference collection, and then instantly output your bibliography in any Wiley journal style.
Download Reference Style for this Journal: If you already use EndNote, you can download the reference style for this journal.
How to Order: To learn more about EndNote, or to purchase your own copy, click here.
Technical Support: If you need assistance using EndNote, contact endnote@isiresearchsoft.com, or visit www.endnote.com/support.
References should be listed in alphabetical order with older papers cited first.
Tables with full legends on a separate page, numbered in Arabic in order of appearance, with a title, and keyed into text.
Legends to figures on a separate page, numbered in Arabic in order of appearance.
Illustrations
Figures should not duplicate information already presented in tabular form. Black and white figures and illustrations may be submitted in electronic format with the software used clearly identified. All graphics and lettering must be legible after reduction to 25% of original size. Figures must be numbered in order of appearance in the text with Arabic numerals. Color figures should be used sparingly and where the use of color is essential to conveying pertinent scientific information. Authors are responsible for the cost of color reproduction ($950 for the first page) and must indicate agreement to pay such charges prior to acceptance of their paper. For best reproduction, bright, clear colors should be used. Dark colors against a dark background do not reproduce well; please place your color images against a white background wherever possible. Please contact Karen Accavallo via e-mail at kaccaval@wiley.com for further information. All graphics and lettering must be legible after reduction in size. Illustrations must be numbered in order of appearance with arabic numerals and keyed into the text. Name of author, figure number, reduction requested, and an arrow indicating the orientation should be typed on a gummed label and affixed to the back of each illustration. Do not write directly on the back of the photo. An illustration or group of illustrations should not exceed 6-3/4¡± wide by 8-3/4¡± long (approximately 17.1 cm by 22.2 cm). Illustrations should be enclosed in an envelope.
Reference style
Cite in text as Smith and Jones [2001], Smith and Jones [2002a,b], or Smith et al. [2002]. Parenthetical citations appear as [Smith and Jones, 2002], etc. Abbreviations for journals used in the reference list should conform to Index Medicus. Refer to the following examples when preparing citations:
Journal Article (list all authors and avoid use of et al.):
Smith A, Jones B. 2002. Full article title. Jrnl Abbr 1:20¨C29.
Books:
Smith A, Jones B. 2002. Complete book title. New York: John Wiley & Sons. 300 p.
Chapter in Book:
Smith A. 2002. Full chapter title: including subtitle, if any. In: Jones B, editor. Book title in full. New York: Wiley-Liss. p 12-34.
Manuscripts for consideration by Drug Development Research must be submitted solely to this journal, and may not have been published in another publication of any type, professional or lay. The journal will not be responsible for loss of manuscripts at any time. Upon acceptance of a manuscript for publication, the corresponding author will be required to sign an agreement transferring copyright to the publisher. All such manuscripts become the property of the publisher, and no material published in Drug Development Research may be reproduced or published elsewhere without written permission from the publisher, who reserves copyright.
Any possible conflict of interest, financial or otherwise, related to the submitted work must be clearly indicated in the manuscript, or in a cover letter accompanying the submission.
All statements in, or omissions from, published manuscripts are the responsibility of authors, who will be asked to review proofs prior to publication. Reprint order forms will be sent with the page proofs. No page charges will be levied against authors or their institutions for publication in the journal.
Disk Submission Instructions
Please return your final, revised manuscript on disk as well as hard copy.
The hard copy must match the disk.
The Journal strongly encourages authors to deliver the final, revised version of their accepted manuscripts (text, tables, and, if possible, illustrations) on disk. Given the near-universal use of computer word-processing for manuscript preparation, we anticipate that providing a disk will be convenient for you, and it carries the added advantages of maintaining the integrity of your keystrokes and expediting typesetting. Please return the disk submission slip below with your manuscript and labeled disk(s).
Guidelines for Electronic Submission
Text
Storage medium. 3-1/2" high-density disk in IBM MS-DOS, Windows, or Macintosh format.
Software and format. Microsoft Word 6.0 is preferred, although manuscripts prepared with any other microcomputer word processor are acceptable. Refrain from complex formatting; the Publisher will style your manuscript according to the Journal design specifications. Do not use desktop publishing software such as Aldus PageMaker or Quark XPress. If you prepared your manuscript with one of these programs, export the text to a word processing format. Please make sure your word processing program's "fast save" feature is turned off. Please do not deliver files that contain hidden text: for example, do not use your word processor's automated features to create footnotes or reference lists.
File names. Submit the text and tables of each manuscript as a single file. Name each file with your last name (up to eight letters). Text files should be given the three-letter extension that identifies the file format. Macintosh users should maintain the MS-DOS "eight dot three" file-naming convention.
Labels. Label all disks with your name, the file name, and the word processing program and version used.
Illustrations
All print reproduction requires files for full color images to be in a CMYK color space. If possible, ICC or ColorSync profiles of your output device should accompany all digital image submissions.
Storage medium. Submit as separate files from text files, on separate disks or cartridges. If feasible, full color files should be submitted on separate disks from other image files. 3-1/2" high-density disks, CD, Iomega Zip, and 5 1/4" 44- or 88-MB SyQuest cartridges can be submitted. At authors' request, cartridges and disks will be returned after publication.
Software and format. All illustration files should be in TIFF or EPS (with preview) formats. Do not submit native application formats.
Resolution. Journal quality reproduction will require greyscale and color files at resolutions yielding approximately 300 ppi. Bitmapped line art should be submitted at resolutions yielding 600-1200 ppi. These resolutions refer to the output size of the file; if you anticipate that your images will be enlarged or reduced, resolutions should be adjusted accordingly.
File names. Illustration files should be given the 2- or 3-letter extension that identifies the file format used (i.e., .tif, .eps).
Labels. Label all disks and cartridges with your name, the file names, formats, and compression schemes (if any) used. Hard copy output must accompany all files.
Print and return with labeled diskette(s)
Corresponding author's name:
|
E-mail address:
|
Telephone:
| |
Manuscript number:
|
Type of computer:
|
Program(s) & version(s) used:
| |
|
|
I certify that the material on the enclosed diskette(s) is identical in both word and content to the printed copy herewith enclosed.
Signature: ______________________________________________ Date: _____________
Production Questions
Karen Accavallo
E-mail: kaccaval@wiley.com
Editorial Board
E d i t o r s - I n - C h i e f
|
Michael Williams
Department of Molecular Pharmacology and Biological Chemistry
Northwestern University Medical School
Chicago, IL 60611
Fax: 847-615-8547
E-mail: mazarine1643@comcast.net
|
Flaminio Cattabeni
Department of Pharmacological Sciences
University of Milan
Via Balzaretti 9
20133 Milan, Italy
Fax: 39-02-5031-8284
Email: E-mail: flaminio.cattabeni@unimi.it
| |
S e c t i o n E d i t o r s
|
Biotechnology/Biopharmaceuticals
Walter H. Moos
MitoKor
Diversity
David J. Triggle
State University of New York at Buffalo
|
Medicinal Chemistry
F. Ivy Carroll
Research Triangle Institute
Pharmacogenomics
David Gurwitz
Tel Aviv University
|
Pharmacological Sciences
Christopher J. Triggle
University of Calgary
|
E d i t o r i a l B o a r d
|
Maria Pia Abbracchio
University of Milan
Stephen P. Arneric
Pharmacia
John F. Beary III
Proctor & Gamble
Jorge D. Brioni
Abbott Laboratories
Bryan F. Cox
Abbott Laboratories
Alan W. Cuthbert
University of Cambridge
Neal Cutler
California Clinical Trials
John Fozard
Novartis
Manfred Gothert
University of Bonn
Adrian IJzerman
Gorlaeus Laboratories
Kenneth A. Jacobson
National Institutes of Health
|
Michael F. Jarvis
Abbott Laboratories
Lars Knutsen
Ionix Pharmaceuticals Ltd.
Donald Kyle Purdue Pharma
Edward D. Levin
Duke University
Alan J. Lewis
Signal Pharmaceuticals
Kevin Mullane
Inflazyme Pharmaceuticals
Roger D. Porsolt
Porsolt & Partners Pharmacology
Alice Sapienza
Simmons College
Bert Spilker
PhRMA
Diana Stork
University of Hartford
Juan Tamargo
Universidad Complutense de Madrid
| |
J o u r n a l P r o d u c t i o n
|
John Wiley & Sons
Karen Accavallo
E-mail: kaccaval@wiley.com
Drug Development Research
|
| 
刊名字顺( Alphabetical List of Journals):
返回页首 